Literature DB >> 9773944

Propylthiouracil-induced severe hepatitis: a case report and review of the literature.

Y Ichiki1, M Akahoshi, N Yamashita, C Morita, T Maruyama, T Horiuchi, K Hayashida, H Ishibashi, Y Niho.   

Abstract

A 21-year-old woman was diagnosed as having Graves' disease in April, 1995. Thiamazole was administered; about a month later the patient had a skin rash and propylthiouracil (PTU) was given instead. Two months after commencing PTU, she rapidly developed jaundice, accompanied by severe liver damage. The drug-induced lymphocyte stimulating test was positive for PTU and she was diagnosed as having severe hepatitis induced by PTU. After pulse therapy with 500 mg of methylprednisolone was given for 3 days, liver function test results were gradually improved, and became normalized 1 1/2 months after admission. The pathology findings of the liver biopsy sample taken before administration of corticosteroid showed necrosis of hepatocytes predominantly around the central veins (i.e., zone 3 necrosis), and moderate to severe infiltration of lymphocytes and neutrophils in portal areas and lobules. Severe hepatic damage due to PTU is rare; 25 cases have been reported so far in the English-language literature. When we use PTU for patients with hyperthyroidism, we should keep in mind that severe liver damage induced by PTU can be fatal, and we should therefore diagnose it earlier by liver biopsy and lymphocyte stimulating test.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9773944     DOI: 10.1007/s005350050167

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  10 in total

Review 1.  Propylthiouracil for alcoholic liver disease.

Authors:  Giuseppe Fede; Giacomo Germani; Christian Gluud; Kurinchi Selvan Gurusamy; Andrew K Burroughs
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

Review 2.  An overview on the proposed mechanisms of antithyroid drugs-induced liver injury.

Authors:  Reza Heidari; Hossein Niknahad; Akram Jamshidzadeh; Mohammad Ali Eghbal; Narges Abdoli
Journal:  Adv Pharm Bull       Date:  2015-03-05

3.  Propylthiouracyl-induced severe liver toxicity: an indication for alanine aminotransferase monitoring?

Authors:  M Benyounes; C Sempoux; C Daumerie; J Rahier; A P Geubel
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

4.  Steroids for the treatment of methimazole-induced severe cholestatic jaundice in a 74-year-old woman with type 2 diabetes.

Authors:  Mei Zhang; Hongwen Zhou; Ronghua He; Fusong Di; Liu Yang; Tao Yang
Journal:  Endocrine       Date:  2010-01-05       Impact factor: 3.633

Review 5.  Current concepts and controversies in the treatment of alcoholic hepatitis.

Authors:  Catherine Rongey; Neil Kaplowitz
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

6.  Acute-on-chronic liver failure due to thiamazole in a patient with hyperthyroidism and trilogy of Fallot: case report.

Authors:  Chuan Shen; Cai-Yan Zhao; Fang Liu; Ya-Dong Wang; Jun Yu
Journal:  BMC Gastroenterol       Date:  2010-08-14       Impact factor: 3.067

7.  A woman with recent jaundice and pruritus.

Authors:  Bita Behnava; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2010-03-01       Impact factor: 0.660

Review 8.  Liver failure due to antithyroid drugs: report of a case and literature review.

Authors:  Sarantis Livadas; Xenofon Xyrafis; Frangiskos Economou; Georgios Boutzios; Maria Christou; Aristea Zerva; Athanasios Karachalios; Helen Palioura; Sotiria Palimeri; Evanthia Diamanti-Kandarakis
Journal:  Endocrine       Date:  2010-05-18       Impact factor: 3.925

9.  Grave's Disease with Severe Hepatic Dysfunction: A Diagnostic and Therapeutic Challenge.

Authors:  Ashok Krishna Bhuyan; Dipti Sarma; Uma Kaimal Saikia; Bipul Kumar Choudhury
Journal:  Case Rep Med       Date:  2014-09-15

10.  A case of autoimmune hepatitis with Graves' disease treated by propylthiouracil.

Authors:  Ikuko Sato; Taku Tsunekawa; Yuri Shinohara; Yuichiro Nishio; Yuko Shimizu; Yasuhiko Suzuki; Shuko Yoshioka
Journal:  Nagoya J Med Sci       Date:  2011-08       Impact factor: 1.131

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.